Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | Tofacitinib | 0.3 | uM | 4 | IL-15 | 326.0 | 58 | ||||
N2645 | 4 | IL-15 | 313.5 | 66 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 4 | IL-15 | 314.0 | 55 | ||||
RA2708 | 4 | IL-15 | 308.0 | 59 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-15 | 268.0 | 41 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-15 | 432.5 | 64 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-15 | 287.0 | 71 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-15 | 352.0 | 69 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-15 | 314.0 | 55 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-15 | 325.0 | 59 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-15 | 526.0 | 69 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 4 | IL-15 | 723.0 | 63 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-15 | 727.0 | 54 | |
N2645 | Poly(I:C) | 2 | ug/mL | 4 | IL-15 | 1085.0 | 63 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL-15 | 671.5 | 56 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 4 | IL-15 | 541.5 | 74 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-15 | 289.0 | 53 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-15 | 429.0 | 72 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-15 | 349.0 | 61 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-15 | 471.5 | 72 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-15 | 325.0 | 60 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-15 | 381.5 | 64 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-15 | 926.0 | 73 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | IL-15 | 835.0 | 70 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL-15 | 1042.0 | 57 |